Curcuminoid supplementation for vasomotor symptoms in postmenopausal women: a pilot, randomized, double-blind, placebo-controlled proof-of-concept trial.

BMC Complement Med Ther · 2026 · PMC13134235 · PMID 41877056

Europe PMC DOI

hedged sentence

0.1490

closest p · 3.0× alpha

0.1490

boldest claim

The sentences

did not reach statistical significancep = 0.149not close (p > 0.1)

At Week 12, the primary change-score analysis for the MENQOL vasomotor domain did not reach statistical significance ( p = 0.149) (Table 4 , Panel A).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.